Insider trading

Period: 120 months Stock: CVS Minimum amount: $10M × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

17 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

17 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

17 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

17 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
17 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
17 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

17 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
21 May 2026
ROBBINS LARRY Director · indirect
Sold at will
$34.62M 370,462 at 93.45
7.1%
Not planned
20 May 2026
ROBBINS LARRY Director · indirect
Sold at will 4×
$95.51M 1,018,000 at 93.82
16.4%
Not planned
19 May 2026
ROBBINS LARRY Director · indirect
Sold at will 2×
$187.34M 1,983,538 at 94.45
24.2%
Not planned
6 May 2025
ROBBINS LARRY Director · indirect
Sold at will
$10.00M 150,000 at 66.67
1.8%
Not planned
5 May 2025
ROBBINS LARRY Director · indirect
Sold at will 2×
$89.25M 1,323,932 at 67.41
13.7%
Not planned
2 May 2025
ROBBINS LARRY Director · indirect
Sold at will 3×
$154.44M 2,276,068 at 67.86
19.1%
Not planned
15 Dec 2022
Moriarty Thomas M EVP & General Counsel
Sold, plan not stated 2×
$13.52M 137,466 at 98.36
18.4%
3 Aug 2022
Lotvin Alan EVP&President-PharmacyServices
Sold, plan not stated 2×
$11.85M 120,899 at 98.00
52.5%
Sold half or more
28 Jun 2022
Moriarty Thomas M EVP & General Counsel
Sold, plan not stated 3×
$13.17M 138,654 at 95.00
18.1%
3 Nov 2021
Roberts Jonathan C EVP & Chief Operating Officer
Sold, plan not stated
$10.34M 108,870 at 95.00
50.4%
Sold half or more
26 Mar 2021
MERLO LARRY J Director
Sold, plan not stated
$20.23M 270,650 at 74.73
34.1%
15 Jan 2020
MERLO LARRY J President and CEO
Sold, plan not stated
$19.93M 266,476 at 74.79
37.9%
1 Feb 2019
MERLO LARRY J President and CEO
Sold, plan not stated
$10.73M 166,368 at 64.51
33.5%
8 Jan 2019
MERLO LARRY J President and CEO
Sold, plan not stated
$11.49M 166,368 at 69.04
33.5%
13 Sep 2017
MERLO LARRY J President and CEO
Sold, plan not stated
$20.03M 241,150 at 83.07
44.6%
11 Sep 2017
Denton David M EVP and CFO
Sold, plan not stated 3×
$18.88M 237,078 at 79.65
86.8%
Sold half or more
12 Jun 2017
Denton David M EVP and CFO
Sold, plan not stated
$18.44M 230,510 at 80.00
58.3%
Sold half or more
Showing 1–17 of 17.